background image

Paid Clinical Trials Wisconsin

Discover 1,177 paid clinical trials in Wisconsin. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1

Study of Sacituzumab Govitecan in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread

Recruiting
PHASE2

Sponsor:

Gilead Sciences

Location:

Madison, Chicago, Springfield, Ann Arborshow 31 more

Code:

NCT03547973

Conditions

Metastatic Urothelial Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Sacituzumab Govitecan-hziy

Pembrolizumab

Cisplatin

Avelumab

Zimberelimab

A Study of Brepocitinib in Adults With Active, Non-Infectious, Non-Anterior Uveitis

Recruiting
PHASE3

Sponsor:

Priovant Therapeutics, Inc.

Location:

Madison, Rochester, Minneapolis, Ann Arborshow 33 more

Code:

NCT06431373

Conditions

Uveitis, Posterior

Uveitis, Intermediate

Uveitis

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Brepocitinib PO QD

Placebo PO QD

Impact of Bromocriptine on Clinical Outcomes for Peripartum Cardiomyopathy

Recruiting

Sponsor:

Dennis M. McNamara, MD, MS

Location:

Milwaukee, Rochester, Minneapolis, Chicagoshow 43 more

Code:

NCT05180773

Conditions

Peripartum Cardiomyopathy, Postpartum

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Bromocriptine

Placebo

Guideline Directed Medical Therapy for Heart Failure (GDMT)

Rivaroxaban

Second Placebo

A Study Evaluating the Efficacy and Safety of Oral Etrasimod in the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease

Recruiting
PHASE3

Sponsor:

Pfizer

Location:

Milwaukee, Gurnee, Libertyville, Lake Bluffshow 93 more

Code:

NCT04173273

Conditions

Crohn's Disease

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Etrasimod

Placebo

A Study in Participants With Advanced Cancers Associated With Expression of DLL3 (MK-6070-001/HPN328-4001)

Recruiting
PHASE1
PHASE2

Sponsor:

Harpoon Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

Location:

Milwaukee, Detroit, Cleveland, Buffaloshow 7 more

Code:

NCT04471727

Conditions

Small-Cell Lung Cancer

Neuroendocrine Carcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

MK-6070

Atezolizumab

Ifinatamab Deruxtecan (I-DXd)

Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis

Recruiting
PHASE3

Sponsor:

Sanofi

Location:

Milwaukee, Northbrook, Evanston, Minneapolisshow 78 more

Code:

NCT06141473

Conditions

Multiple Sclerosis

Eligibility Criteria

Sex: All

Age: 18 - 55

Healthy Volunteers: Not accepted

Interventions

Frexalimab

Teriflunomide

Placebo infusion

Placebo tablet

MRI contrast-enhancing agents

A Study to Evaluate Safety, Efficacy of FF-10832 in Combo With Pembrolizumab in Urothelial & Non-small Cell Lung Cancer

Recruiting
PHASE2

Sponsor:

Fujifilm Pharmaceuticals U.S.A., Inc.

Location:

Madison, Sioux Falls, Detroit, Saint Louisshow 16 more

Code:

NCT05318573

Conditions

Advanced Urothelial Carcinoma

Advanced Non Small Cell Lung Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Pembrolizumab

FF-10832

Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma

Recruiting
PHASE2

Sponsor:

Harry H Yoon

Location:

Milwaukee, Rochester

Code:

NCT04069273

Conditions

Gastric Cancer

GastroEsophageal Cancer

Adenocarcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Pembrolizumab Monotherapy

Ramucirumab

Paclitaxel

Comparison of Methods of Pulmonary Blood Flow Augmentation in Neonates: Shunt Versus Stent (The COMPASS Trial)

Recruiting

Sponsor:

Carelon Research

Location:

Wauwatosa, Ann Arbor, Saint Louis, Cincinnatishow 20 more

Code:

NCT05268094

Conditions

Congenital Heart Disease in Children

Eligibility Criteria

Sex: All

Age: 1 - 30

Healthy Volunteers: Not accepted

Interventions

Ductal Arterial Stent

Systemic-to-Pulmonary Artery Shunt

Enlighten Study: The EV-ICD Post Approval Registry

Recruiting

Sponsor:

Medtronic

Location:

Milwaukee, Rochester, Minneapolis, Coon Rapidsshow 47 more

Code:

NCT06048731

Conditions

Ventricular Arrhythmia

Tachycardia

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

Defibrillation using EV-ICD

Popular cities in Wisconsin

The state of Wisconsin offers a substantial healthcare network and renowned medical research institutions, making it a prime location for clinical research into a variety of conditions. Leading centers such as the University of Wisconsin School of Medicine and Public Health, the Medical College of Wisconsin, and Froedtert Hospital are state leaders in medical research. These institutions, known for their innovative approaches, provide a strong foundation for conducting clinical trials that advance medical knowledge and treatment options.

Why choose Wisconsin for clinical trials?

Common conditions studied in Wisconsin

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Wisconsin